January 28, 2021 "If we see that there are inconsistencies, that the vaccine doses that should remain in the EU are destined for export, there will be the possibility of intervening by denying the authorization. It is rare, but it could happen".

This is how EU sources explain how the transparency mechanism for the export of vaccines will work, an initiative that the European Commission is about to implement after noting "lack of clarity, deficiencies" and situations to be "monitored and addressed".

It is "a tool to protect vaccines for which the EU has pre-purchase agreements".

The involvement of the European Commission "in the new EU mechanism for registering and authorizing the export of vaccine doses" has yet to be established ", but the general idea is that" the national authorities ask us for an opinion before giving the authorization "At export, a senior EU function said about the mechanism that will be announced publicly tomorrow." These details have yet to be discussed, "added the EU source about the effective powers in the hands of Brussels. For sure, by effect of the new EU mechanism, "a form will be distributed that companies (pharmaceuticals, ed) who want to export (vaccine doses, ed) will have to fill and send to national authorities".

"All companies that export" vaccines "will then send to the authorities the national

their export plans "that include information" on the amount and type of vaccine and where will the doses. "" it takes a fast, "concluded the func


WHO: Governments and manufacturers work together

L '


, assured that the producers of vaccines Covid-19 are working tirelessly to resolve the deficit issue in supplies and asked the governments of various countries to wait and not contend the doses.

To speak is the WHO director for Europe, Hans Kluge, according to which governments and pharmaceutical companies must work together to solve the "initial problems" of the vaccination campaign.

"The reality is that there is a shortage of vaccines," said Kluge, "but we have no doubt that manufacturers are working 24/7 to fill the gaps and we are convinced that the delays we are seeing now will be solved with extra production in the future ".

Kluge stressed that solidarity "does not necessarily mean that every country in the world must start vaccinating at exactly the same time, but it is important to recognize that no one is safe before everyone is safe". 

AstraZeneca ready to increase production

To increase the production of its vaccine, 


 does not rule out the expansion of the number of factories in Europe but, given the necessary requirements, considers it 'very difficult'.

The company is working to resolve the slowdown at its Belgium plant for manufacturing the active substance.

From that of Anagni, in charge of filling the doses, the vials will not be distributed directly in Italy but other validation steps will be necessary first in other countries.

Germany: lack for another 10 weeks



will have a shortage of anti Covid vaccines for at least another 10 weeks, until April.

This was announced by the Minister of Health, Jens Spahn.

"We still have at least 10 tough weeks ahead of a shortage" of vaccines, Spahn wrote on his Twitter profile.